Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PIC subject to iron unit-dose packaging requirement, FDA tells Schwarz Pharma.

This article was originally published in The Tan Sheet

Executive Summary

PIC SUBJECT TO IRON UNIT-DOSE PACKAGING REQUIREMENTS, FDA SAYS in a July 17 denial of a citizen petition by Schwarz Pharma requesting that polysaccharide-iron complex (PIC) be exempt from the final rule requiring unit-dose packaging for products containing 30 mg or more of iron per dosage unit. The company had asked FDA to first temporarily exclude the ingredient and, after a future submission of animal data comparing the toxicity of PIC to iron salts, make the exemption permanent ("The Tan Sheet" April 28, p. 7). The FDA final rule, in addition to mandating unit-dose packaging, calls for label warnings on iron-containing supplements in solid oral dosage form ("The Tan Sheet" Jan. 20, pp. 1-4).
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087387

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel